← Back to headlines
Biohaven Reports Q1 Earnings, Misses EPS Estimates
Biohaven Pharmaceutical Holding Company reported a GAAP EPS of -$0.88 for the first quarter, missing analyst expectations by $0.04.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
